Decheng Capital

  • About Us
  • Team
  • Portfolio
  • News
  • Contact

A Global Life Sciences Investment Firm

Established in 2012

$2.1 Billion of Capital

Building Legendary Companies

In The News

December 1, 2020 IMPACT Therapeutics Announces $50 Million Series C+ Financing
November 10, 2020 Exclusive: Decheng's Inside View of Merck's $2.75 Billion Acquisition of VelosBio
November 5, 2020 Merck to Acquire VelosBio
October 13, 2020 Exclusive: How Sequencing Firm ReadCoor Came to be Acquired by 10x Genomics
October 11, 2020 Cue Receives $481 Million Award by DOD and HHS to Expand Domestic Production Capacity and Provide 6 Million Molecular, Point-of-Care COVID-19 Tests
October 9, 2020 Everest Medicines soars on debut after $451m IPO
October 7, 2020 UC Berkeley’s Jennifer Doudna wins 2020 Nobel Prize in Chemistry
October 5, 2020 10x Genomics to Acquire ReadCoor for $350M
September 23, 2020 Exclusive: The Story Behind How Cirina, a $12 Million Hong Kong Diagnostics Startup, Became Part of Illumina
September 21, 2020 Illumina to Acquire GRAIL to Launch New Era of Cancer Detection
August 6, 2020 Checkmate Pharmaceuticals Announces Pricing of Initial Public Offering
July 28, 2020 Sema4 Closes $121 Million Series C Led by BlackRock
July 8, 2020 VelosBio Raises $137 Million in Series B Financing to Advance Development of ROR1-Directed Therapeutics in Oncology
June 25, 2020 Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies
June 18, 2020 Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101
June 12, 2020 Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test
June 10, 2020 Checkmate Pharmaceuticals Secures $85 Million in Series C Financing
June 4, 2020 Everest Medicines Completes US$310 Million Series C Financing
May 27, 2020 Gilead Sciences and Arcus Biosciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies
May 21, 2020 Mindstrong Announces $100M Funding Round to Scale its Virtual Mental Healthcare & Digital Symptom Measurement Offering
May 21, 2020 GSK Taps Mammoth Biosciences to Develop a CRISPR-based, Over-the-counter Coronavirus Test
May 10, 2020 Hummingbird Bioscience Closes US$25 Million Investment With Series B Extension
May 6, 2020 GRAIL Announces $390 Million Series D Financing
January 31, 2020 Star-Studded Mammoth Bio Raises $45 Million for Crispr R&D
January 10, 2020 Harvard Spinout ReadCoor Raises $27M in Series B Financing
January 9, 2020 Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform

Archive

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012

    • Silicon Valley
    • Shanghai
    • New York